Phlecs

Phlecs builds on 15 years of clinical and technological research conducted at Philips to develop a unique and effective range of light therapy devices for the treatment of inflammatory skin diseases. Blue light therapy is a clinically proven approach for conditions such as itching and eczema (atopic dermatitis), offering effective relief without the burden of severe side effects, low adherence, or lengthy treatment protocols. It is safe, cost-effective, and positioned to replace traditional UV phototherapy, which relies on mercury lamps that will be banned by the EU in the coming years. In collaboration with a Dutch consortium, Phlecs is currently developing a home-use device, enabling patients to access treatment whenever and wherever they need it. More information at: https://www.phlecs.com/home-phototherapy/